COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2

The COVID-19 pandemic is an unprecedented challenge and will require novel therapeutic strategies. Affected patients are likely to be at risk of arrhythmia due to underlying comorbidities, polypharmacy and the disease process. Importantly, a number of the medications likely to receive significant us...

Descripción completa

Detalles Bibliográficos
Autores principales: Carpenter, Alexander, Chambers, Owen J., El Harchi, Aziza, Bond, Richard, Hanington, Oliver, Harmer, Stephen C., Hancox, Jules C., James, Andrew F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214683/
https://www.ncbi.nlm.nih.gov/pubmed/32432127
http://dx.doi.org/10.3389/fcvm.2020.00085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214683/
https://www.ncbi.nlm.nih.gov/pubmed/32432127
http://dx.doi.org/10.3389/fcvm.2020.00085

Ejemplares similares